Exploring the role of epigenetic dysregulation in PanNET progression
Sita Kugel, PhD
Finished Projects
Fluorine-18 labeled MIBG analogues for theranostic applications
David Raffel, PhD
Functionalized silica nanoparticles: development of a combined PET and TAT theranostic agent for NETs
Tara Mastren, PhD
Generate mouse models of neuroendocrine cancer
Seung Kim, MD, PhD
Generation and characterization of a novel genetically modified patient–derived NET organoid system
James Yao, MD
Hypoxia Onco-metabolic Drivers in Pancreatic and Small Intestine NET
Amit Tirosh, MD
Identify and validate molecular targets for therapy in a newly developed human midgut carcinoid tumor cell line
Lee Ellis, MD
Identifying altered epigenetic states and drivers in intestinal carcinoid and pancreatic NETs
Bradley Bernstein, MD, PhD
Implication of heterogeneous innate immune cells in pancreatic NET resistance
Gabriele Bergers, PhD
Improving imaging and Endoradiotherapy of NETs by endocytic modulation of somatostatin receptors
Patrícia Ribeiro Pereira, PhD